228 related articles for article (PubMed ID: 17325342)
21. Inhibition growth and metastasis of melanoma by 4-1BBL expressed in normal tissue cells by regulating the function of immune cells.
Hui Q; Yu X; Hui Z; Zuohua F
Cancer Biother Radiopharm; 2009 Oct; 24(5):597-605. PubMed ID: 19877890
[TBL] [Abstract][Full Text] [Related]
22. Adoptively transferred tumor-specific T cells stimulated ex vivo using herpes simplex virus amplicons encoding 4-1BBL persist in the host and show antitumor activity in vivo.
Yi KH; Nechushtan H; Bowers WJ; Walker GR; Zhang Y; Pham DG; Podack ER; Federoff HJ; Tolba KA; Rosenblatt JD
Cancer Res; 2007 Oct; 67(20):10027-37. PubMed ID: 17942937
[TBL] [Abstract][Full Text] [Related]
23. Rejection of disseminated metastases of colon carcinoma by synergism of IL-12 gene therapy and 4-1BB costimulation.
Chen SH; Pham-Nguyen KB; Martinet O; Huang Y; Yang W; Thung SN; Chen L; Mittler R; Woo SL
Mol Ther; 2000 Jul; 2(1):39-46. PubMed ID: 10899826
[TBL] [Abstract][Full Text] [Related]
24. Comparative analysis of antitumor activity of CD40L, RANKL, and 4-1BBL in vivo following intratumoral administration of viral vectors or transduced dendritic cells.
Yurkovetsky ZR; Shurin GV; Barry DA; Schuh AC; Shurin MR; Robbins PD
J Gene Med; 2006 Feb; 8(2):129-37. PubMed ID: 16288496
[TBL] [Abstract][Full Text] [Related]
25. Regulating immunity and inhibiting tumor growth by the recombinant peptide sPD-1-CH50.
Qiu H; Liu S; Xie C; Long J; Feng Z
Anticancer Res; 2009 Dec; 29(12):5089-94. PubMed ID: 20044621
[TBL] [Abstract][Full Text] [Related]
26. Nanobubbles Containing sPD-1 and Ce6 Mediate Combination Immunotherapy and Suppress Hepatocellular Carcinoma in Mice.
Tan Y; Yang S; Ma Y; Li J; Xie Q; Liu C; Zhao Y
Int J Nanomedicine; 2021; 16():3241-3254. PubMed ID: 34007176
[TBL] [Abstract][Full Text] [Related]
27. IL-6 and PD-L1 blockade combination inhibits hepatocellular carcinoma cancer development in mouse model.
Liu H; Shen J; Lu K
Biochem Biophys Res Commun; 2017 Apr; 486(2):239-244. PubMed ID: 28254435
[TBL] [Abstract][Full Text] [Related]
28. Intratumoral neoadjuvant immunotherapy using IL-12 and dendritic cells is an effective strategy to control recurrence of murine hepatocellular carcinoma in immunosuppressed mice.
Kayashima H; Toshima T; Okano S; Taketomi A; Harada N; Yamashita Y; Tomita Y; Shirabe K; Maehara Y
J Immunol; 2010 Jul; 185(1):698-708. PubMed ID: 20498356
[TBL] [Abstract][Full Text] [Related]
29. In situ expression of soluble B7-1 in the context of oncolytic herpes simplex virus induces potent antitumor immunity.
Todo T; Martuza RL; Dallman MJ; Rabkin SD
Cancer Res; 2001 Jan; 61(1):153-61. PubMed ID: 11196154
[TBL] [Abstract][Full Text] [Related]
30. STAT3-blocked whole-cell hepatoma vaccine induces cellular and humoral immune response against HCC.
Han Q; Wang Y; Pang M; Zhang J
J Exp Clin Cancer Res; 2017 Nov; 36(1):156. PubMed ID: 29115974
[TBL] [Abstract][Full Text] [Related]
31. A novel antibody-4-1BBL fusion protein for targeted costimulation in cancer immunotherapy.
Müller D; Frey K; Kontermann RE
J Immunother; 2008 Oct; 31(8):714-22. PubMed ID: 18779748
[TBL] [Abstract][Full Text] [Related]
32. [Antitumor effect of gene therapy with recombinant adenovirus-mediated human interleukin-2 gene transfer and its mechanism].
Du J; Ran Y; Lin Z; Zheng C; Wei H; Wang X; Zhou L; Ren Y
Sichuan Da Xue Xue Bao Yi Xue Ban; 2003 Jan; 34(1):12-5. PubMed ID: 15600167
[TBL] [Abstract][Full Text] [Related]
33. 4-1BBL enhances anti-tumor responses in the presence or absence of CD28 but CD28 is required for protective immunity against parental tumors.
Guinn BA; Bertram EM; DeBenedette MA; Berinstein NL; Watts TH
Cell Immunol; 2001 May; 210(1):56-65. PubMed ID: 11485353
[TBL] [Abstract][Full Text] [Related]
34. HSP70 vaccine in combination with gene therapy with plasmid DNA encoding sPD-1 overcomes immune resistance and suppresses the progression of pulmonary metastatic melanoma.
Geng H; Zhang GM; Xiao H; Yuan Y; Li D; Zhang H; Qiu H; He YF; Feng ZH
Int J Cancer; 2006 Jun; 118(11):2657-64. PubMed ID: 16425224
[TBL] [Abstract][Full Text] [Related]
35. Synergistic effects of soluble PD-1 and IL-21 on antitumor immunity against H22 murine hepatocellular carcinoma.
Pan XC; Li L; Mao JJ; Yao W; Zheng JN; Liu M; Fu JJ
Oncol Lett; 2013 Jan; 5(1):90-96. PubMed ID: 23255900
[TBL] [Abstract][Full Text] [Related]
36. Role of 4-1BB:4-1BB ligand in cancer immunotherapy.
Cheuk AT; Mufti GJ; Guinn BA
Cancer Gene Ther; 2004 Mar; 11(3):215-26. PubMed ID: 14671675
[TBL] [Abstract][Full Text] [Related]
37. Analysis of 4-1BB ligand (4-1BBL)-deficient mice and of mice lacking both 4-1BBL and CD28 reveals a role for 4-1BBL in skin allograft rejection and in the cytotoxic T cell response to influenza virus.
DeBenedette MA; Wen T; Bachmann MF; Ohashi PS; Barber BH; Stocking KL; Peschon JJ; Watts TH
J Immunol; 1999 Nov; 163(9):4833-41. PubMed ID: 10528184
[TBL] [Abstract][Full Text] [Related]
38. Potent tumor-specific immunity induced by an in vivo heat shock protein-suicide gene-based tumor vaccine.
Ren W; Strube R; Zhang X; Chen SY; Huang XF
Cancer Res; 2004 Sep; 64(18):6645-51. PubMed ID: 15374979
[TBL] [Abstract][Full Text] [Related]
39. Immunizing effects of cocultures of H22 hepatocarcinoma cells and cartilage polysaccharide on murine H22 hepatocarcinoma.
Han X; Liu AJ; Zhao XH; Li YD; Zheng GQ; Zhang GR
J Food Sci; 2010 Oct; 75(8):H265-73. PubMed ID: 21535505
[TBL] [Abstract][Full Text] [Related]
40. Expression of interleukins-23 and 27 leads to successful gene therapy of hepatocellular carcinoma.
Hu P; Hu HD; Chen M; Peng ML; Tang L; Tang KF; Matsui M; Belladonna ML; Yoshimoto T; Zhang DZ; Xiang R; Ren H
Mol Immunol; 2009 May; 46(8-9):1654-62. PubMed ID: 19299021
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
